The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use-Reference-Cited by-同舟云学术

The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use

Published:2017-05 Issue: Volume:33 Page:125-129
ISSN:1389-9457
Container-title:Sleep Medicine
language:en
Short-container-title:Sleep Medicine

Author:

Kollb-Sielecka Marta^ORCID,Demolis Pierre,Emmerich Joseph,Markey Greg,Salmonson Tomas,Haas Manuel

Publisher

Elsevier BV

Subject

General Medicine

Reference9 articles.

1. The hypocretin/orexin system;Ebrahim;J R Soc Med,2002

2. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology;Ligneau;J Pharmacol Exp Ther,2007

3. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients;Lin;Neurobiol Dis,2008

4. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil;Uguen;Br J Pharmacol,2013

5. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial;Dauvilliers;Lancet Neurol,2013

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From past to future: 50 years of pharmacological interventions to treat narcolepsy;Pharmacology Biochemistry and Behavior;2024-08

2. Hits and misses with animal models of narcolepsy and the implications for drug discovery;Expert Opinion on Drug Discovery;2024-05-15

3. PITOLISANT;Prescriber's Guide;2024-04-18

4. Commentary on Histamine receptor antagonists by Madeleine Ennis and Wilfried Lorenz;Hemodynamics and Immune Defense;2024

5. Active metabolites and potential mechanisms of Notopterygium incisum against obstructive sleep apnea Syndrome (OSAS): network analysis and experimental assessment;Frontiers in Pharmacology;2023-08-31